Biotech company using genomics and AI to discover novel small-molecule medicines from microbial genomes.
About
Hexagon Bio is a biopharmaceutical company that leverages a proprietary interdisciplinary platform combining machine learning, genomics, synthetic biology, and automation. They mine microbial genomes to discover and develop structurally diverse small-molecule therapeutics for oncology and infectious diseases.
Tags
Total Employees
67
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
62Traction
57Team
30Visibility
5Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Hexagon do?
Hexagon Bio is a biopharmaceutical company that leverages a proprietary interdisciplinary platform combining machine learning, genomics, synthetic biology, and automation. They mine microbial genomes to discover and develop structurally diverse small-molecule therapeutics for oncology and infectious diseases.
How much funding has Hexagon raised?
Hexagon has raised a total of $61M in funding. The most recent round on record is Series A.
Where is Hexagon headquartered?
Hexagon is headquartered in Menlo Park, United States.
When was Hexagon founded?
Hexagon was founded in 2017.
What industry does Hexagon operate in?
Hexagon operates in AI, Biotech, Drug Discovery.
How many employees does Hexagon have?
Hexagon has approximately 67 people on record.